Related Experiment Video
Updated: Aug 11, 2026

Intravital Microscopy of Tumor-associated Vasculature Using Advanced Dorsal Skinfold Window Chambers on Transgenic Fluorescent Mice
Published on: January 19, 2018
Tumor vascular permeabilization by vascular-targeting photosensitization: effects, mechanism, and therapeutic
Bin Chen1, Brian W Pogue, Jorge M Luna
1Department of Surgery, Dartmouth Medical School, Lebanon, New Hampshire, USA.
Purpose:
Loss of vascular barrier function has been observed shortly following vascular-targeting photodynamic therapy. However, the mechanism involved in this event is still not clear, and the therapeutic implications associated with this pathophysiologic change have not been fully explored.
Experimental Design:
The effect of vascular-targeting photodynamic therapy on vascular barrier function was examined in both s.c. and orthotopic MatLyLu rat prostate tumor models and endothelial cells in vitro, using photosensitizer verteporfin. Vascular permeability to macromolecules (Evans blue-albumin and high molecular weight dextran) was assessed with dye extraction (ex vivo) and intravital microscopy (in vivo) methods. Intravital microscopy was also used to monitor tumor vascular functional changes after vascular-targeting photodynamic therapy. The effects of photosensitization on monolayer endothelial cell morphology and cytoskeleton structures were studied with immunofluorescence staining.
Results:
Vascular-targeting photodynamic therapy induced vascular barrier dysfunction in the MatLyLu tumors. Thus, tumor uptake of macromolecules was significantly increased following photodynamic therapy treatments. In addition to vascular permeability increase, blood cell adherence to vessel wall was observed shortly after treatment, further suggesting the loss of endothelial integrity. Blood cell adhesion led to the formation of thrombi that can occlude blood vessels, causing vascular shutdown. However, viable tumor cells were often detected at tumor periphery after vascular-targeting photodynamic therapy. Endothelial cell barrier dysfunction following photodynamic therapy treatment was also observed in vitro by culturing monolayer endothelial cells on Transwell inserts. Immunofluorescence study revealed microtubule depolymerization shortly after photosensitization treatment and stress actin fiber formation thereafter. Consequently, endothelial cells were found to retract, and this endothelial morphologic change led to the formation of intercellular gaps.
Conclusions:
Vascular-targeting photodynamic therapy permeabilizes blood vessels through the formation of endothelial intercellular gaps, which are likely induced via endothelial cell microtubule depolymerization following vascular photosensitization. Loss of endothelial barrier function can ultimately lead to tumor vascular shutdown and has significant implications in drug transport and tumor cell metastasis.
Insights
Vascular-targeting photodynamic therapy disrupts endothelial cell barriers, increasing vascular permeability and potentially leading to tumor vascular shutdown. This mechanism involves microtubule depolymerization and has implications for drug delivery and metastasis.
Area of Science:
- Oncology
- Biomedical Engineering
- Vascular Biology
Background:
- Vascular barrier dysfunction is a known outcome of vascular-targeting photodynamic therapy (VT-PDT).
- The precise mechanisms and therapeutic consequences of this barrier loss remain incompletely understood.
Purpose of the Study:
- To investigate the impact of VT-PDT on vascular barrier function.
- To elucidate the cellular mechanisms underlying VT-PDT-induced vascular permeability.
- To explore the implications of these changes for tumor vascular function and drug delivery.
Main Methods:
- VT-PDT was applied to MatLyLu prostate tumor models (subcutaneous and orthotopic) and endothelial cells in vitro using verteporfin.
- Vascular permeability was assessed using Evans blue-albumin and high molecular weight dextran.
- Intravital microscopy monitored tumor vascular changes, while immunofluorescence studied endothelial cell morphology and cytoskeleton.
Main Results:
- VT-PDT induced significant vascular barrier dysfunction in tumors, increasing macromolecule uptake.
- Endothelial cell retraction and intercellular gap formation were observed, linked to microtubule depolymerization and actin stress fiber formation.
- Blood cell adhesion, thrombus formation, and subsequent vascular shutdown were noted, alongside viable tumor cells at the periphery.
Conclusions:
- VT-PDT causes vascular permeabilization via endothelial intercellular gap formation, driven by photosensitization-induced microtubule depolymerization.
- The loss of endothelial barrier function can result in tumor vascular shutdown.
- These findings highlight significant implications for drug transport and tumor cell metastasis in VT-PDT treatments.
Related Concept Videos
Tumor Immunotherapy
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Mechanism of Angiogenesis
The Tumor Microenvironment
